Stephen R Tabet

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men
    Stephen R Tabet
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    J Acquir Immune Defic Syndr 33:476-83. 2003
  2. ncbi request reprint Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study
    Daniel M Corey
    Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA
    J Acquir Immune Defic Syndr 44:451-5. 2007
  3. ncbi request reprint The natural history of untreated HIV infection in Lima, Peru: implications for clinical trial endpoints for HIV vaccines
    Daniel Corey
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA
    Hum Vaccin 1:160-4. 2005
  4. ncbi request reprint Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men
    Corey Casper
    Department of Medicine, University of Washington, Seattle, WA 98195, USA
    J Infect Dis 185:990-3. 2002
  5. ncbi request reprint Safety and acceptability of the Reality condom for anal sex among men who have sex with men
    Cristina Renzi
    Department of Medicine, University of Washington, Seattle 98104, USA
    AIDS 17:727-31. 2003
  6. ncbi request reprint Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert
    H Nina Kim
    Departments of Medicine, University of Washington, Seattle, WA, USA
    Vaccine 24:532-9. 2006

Detail Information

Publications6

  1. ncbi request reprint Safety and acceptability of penile application of 2 candidate topical microbicides: BufferGel and PRO 2000 Gel: 3 randomized trials in healthy low-risk men and HIV-positive men
    Stephen R Tabet
    Department of Medicine, University of Washington, Seattle, WA 98104, USA
    J Acquir Immune Defic Syndr 33:476-83. 2003
    ....
  2. ncbi request reprint Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study
    Daniel M Corey
    Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109, USA
    J Acquir Immune Defic Syndr 44:451-5. 2007
    ..The prolonged effectiveness of antiretroviral therapy (ART) in a developing country is not well established...
  3. ncbi request reprint The natural history of untreated HIV infection in Lima, Peru: implications for clinical trial endpoints for HIV vaccines
    Daniel Corey
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98109, USA
    Hum Vaccin 1:160-4. 2005
    ..5 years. If clinical endpoints are required to evaluate the clinical effectiveness of T cell based vaccines, extended clinical follow-up of subjects enrolled in such trials will be required...
  4. ncbi request reprint Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men
    Corey Casper
    Department of Medicine, University of Washington, Seattle, WA 98195, USA
    J Infect Dis 185:990-3. 2002
    ..Reporting > or =1 HIV-positive partner (OR, 5.9; 95% CI, 1.8-19.3), amyl nitrite use (OR, 7.0; 95% CI, 2.1-23.0), and lymphadenopathy in the past 6 months (OR, 7.7; 95% CI, 1.9-31.0) correlated with KSHV seroconversion...
  5. ncbi request reprint Safety and acceptability of the Reality condom for anal sex among men who have sex with men
    Cristina Renzi
    Department of Medicine, University of Washington, Seattle 98104, USA
    AIDS 17:727-31. 2003
    ..To assess safety and acceptability of Reality condoms for anal sex among men who have sex with men...
  6. ncbi request reprint Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert
    H Nina Kim
    Departments of Medicine, University of Washington, Seattle, WA, USA
    Vaccine 24:532-9. 2006
    ..A standardized HAART protocol for HIV-1 vaccine efficacy trial participants who become HIV-infected is essential to the evaluation of CTL-based HIV-1 vaccines on the natural history of HIV-1 infection...